Most Read Articles
Audrey Abella, 16 Feb 2017
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) during acute respiratory infection episodes may increase the risk of acute myocardial infarction (MI), a recent study from Taiwan shows.
Pearl Toh, 01 Mar 2016
Asthma development in young children may be associated with paracetamol exposure during maternal pregnancy or infancy, a new study on the MoBa* cohort showed.
Stephen Padilla, 04 Dec 2017
About one in five (~20 percent) of lower respiratory tract illnesses (LRTIs) involve respiratory viruses irrespective of the presence of asthma exacerbation, according to a Korea study presented at the 22nd Congress of the Asian Pacific Society of Respirology (APSR) held in Sydney, Australia.
Pearl Toh, 06 Jan 2017
The experimental Ebola virus vaccine rVSV-ZEBOV shows 100 percent efficacy in protecting against the disease, assessed from day 10 onwards, according to final data from the Ebola ça Suffit!* (which translates to “Ebola that’s enough!”) trial in Guinea and Sierra Leone.

CPAP improves altered plasma fibrin clot properties in hypertensive patients with OSA

17 Apr 2017

Treatment with continuous positive airway pressure (CPAP) significantly improves unfavourable prothrombotic fibrin clot characteristics, including hypofibrinolysis, which are common in hypertensive patients with obstructive sleep apnoea (OSA), according to a recent study.

A total of 50 hypertensive patients with clinically significant OSA (age 50.0 ±8.8 years; 39 males) were analysed, and 38 hypertensive patients with OSA balanced for age, sex, blood pressure, cardiovascular risk factors and metabolic status served as controls. Researchers determined plasma fibrin clot properties, including clot permeability coefficient, clot lysis time (CLT) and turbidimetric parameters of clot formation.

OSA patients had more compact fibrin structure (lower median clot permeability coefficient, 6.00 vs 7.25 10−9 cm2; p<0.001), impaired fibrinolysis (longer median CLT, 108.00 vs 92.50 min; p<0.001) and faster clot formation (shorter median lag phase, 40.50 vs 42.50 s; p=0.041), and higher median maximum clot absorbency indicating denser fibrin networks (0.87 vs 0.81; p=0.028) than controls.

Clot permeability coefficient and CLT were associated with apnoea‒hypopnoea index (r=‒0.46; p<0.001 and r=0.44; p<0.001, respectively) as well as with mean (r=0.31; p=0.003; r=‒0.36; p=0.001, respectively) and minimal oxygen saturation (r=0.46; p<0.001; r=‒0.49; p<0.001, respectively).

Treatment with CPAP for 3 months resulted in an increase in clot permeability coefficient (5.95 vs 7.60 10−9 cm2; p=0.001), shortened CLT (107.00 vs 87.00; p=0.006), a longer lag phase of fibrin formation (40.00 vs 43.50 s; p=0.013) and a trend toward lower maximum clot absorbency (0.86 vs 0.81; p=0.058).

A 2011 study found that CPAP treatment for OSA improves postprandial triglyceride concentration curve and cholesterol levels, which may reduce the risk of cardiovascular events. [Am J Respir Crit Care Med 2011;184:355-61]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Audrey Abella, 16 Feb 2017
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) during acute respiratory infection episodes may increase the risk of acute myocardial infarction (MI), a recent study from Taiwan shows.
Pearl Toh, 01 Mar 2016
Asthma development in young children may be associated with paracetamol exposure during maternal pregnancy or infancy, a new study on the MoBa* cohort showed.
Stephen Padilla, 04 Dec 2017
About one in five (~20 percent) of lower respiratory tract illnesses (LRTIs) involve respiratory viruses irrespective of the presence of asthma exacerbation, according to a Korea study presented at the 22nd Congress of the Asian Pacific Society of Respirology (APSR) held in Sydney, Australia.
Pearl Toh, 06 Jan 2017
The experimental Ebola virus vaccine rVSV-ZEBOV shows 100 percent efficacy in protecting against the disease, assessed from day 10 onwards, according to final data from the Ebola ça Suffit!* (which translates to “Ebola that’s enough!”) trial in Guinea and Sierra Leone.